Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Blood Adv (2023) 7 (23): 7384–7391.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals